Epiduo 0.1%/2.5% Gel
- Name:
Epiduo 0.1%/2.5% Gel
- Company:
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 14/07/20
(Click to Download)XPIL
Package leaflet: Information for the user
Package leaflet: Information for the user
1. What Epiduo is and what it is used for
1. What Epiduo is and what it is used for
2. What you need to know before you use Epiduo
2. What you need to know before you use Epiduo
3. How to use Epiduo
3. How to use Epiduo
4. Possible side effects
4. Possible side effects
5. How to store Epiduo
5. How to store Epiduo
6. Contents of the pack and other information
6. Contents of the pack and other information
Click on this link to Download PDF directly
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
 Ltd.jpg)
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Acnecide Gel 5% | Active Ingredients Benzoyl Peroxide, hydrous |
| Medicine Name Azzalure | Active Ingredients Botulinum Toxin Type A |
| Medicine Name Curanail 5% w/v Medicated Nail Lacquer | Active Ingredients Amorolfine Hydrochloride |
| Medicine Name Differin Cream 0.1% w/w | Active Ingredients Adapalene |
| Medicine Name Differin Gel | Active Ingredients Adapalene |
| Medicine Name Efracea capsules | Active Ingredients Doxycycline monohydrate |
| Medicine Name Epiduo 0.1%/2.5% Gel | Active Ingredients Adapalene, Benzoyl Peroxide |
| Medicine Name Etrivex 500 micrograms/g Shampoo | Active Ingredients Clobetasol Propionate |
| Medicine Name Loceryl Nail Lacquer | Active Ingredients Amorolfine Hydrochloride |
| Medicine Name Metvix Cream | Active Ingredients Methyl Aminolevulinate Hydrochloride |
| Medicine Name Mirvaso 3mg/g Gel | Active Ingredients brimonidine tartrate |
| Medicine Name Rozex Cream | Active Ingredients Metronidazole |
| Medicine Name Rozex Gel | Active Ingredients Metronidazole |
| Medicine Name Silkis Ointment | Active Ingredients Calcitriol |
| Medicine Name Soolantra 10 mg/g Cream | Active Ingredients Ivermectin |
| Medicine Name Tetralysal 300 Capsules | Active Ingredients Lymecycline |
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 14 July 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
Updated on 14 July 2020 SPC
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.6 - Pregnancy and lactation
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 14 November 2018 PIL
Reasons for updating
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 5 November 2018 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 15 June 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 6 June 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 6 June 2018 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 21 February 2018 PIL
Reasons for updating
- New PIL for new product
Updated on 21 February 2018 PIL
Reasons for updating
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - use in children/adolescents
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
- Correction of spelling/typing errors
Updated on 2 February 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 2 February 2018 SPC
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.1 - List of excipients
- Change to section 10 - Date of revision of the text
- Change to section 2 - Qualitative and quantitative composition
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
- Section 2: (E1520; 4.00%) has been added after 'excipient with known effect: propylene glycol'. This now reads: 'Excipient with known effect: Propylene glycol (E1520; 4.00%)
- Section 4.1: The following has been added: Epiduo is indicated in adults, adolescents and children aged 9 years and over.
- Section 4.5: Minor rewording. 'No interaction studies have been performed
conducted with Epiduo. - Section 4.8: Minor rewording of table headings and the addition of '(cannot be estimated from the available data)*' to the frequency column for Eye disorders; Respiratory, thoracic and mediastinal disorders; and skin and subcutaneous disorders.
- Section 5.1: Pharmacotherapeutic group changed. 'D10A' has been removed, and 'D10AD Retinoids for topical use in acne' has been added. Also a minor spelling change 'forth' to 'fourth'.
- Section 6.1: Change of 'glycerin' to 'glycerol'
- Section 10: Change of date to January 2018.
Updated on 29 September 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 29 September 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)